Rafferty Asset Management’s ImmunityBio IBRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.18M	Sell	545,404 -61,926	-10%	-$424K	0.02%	448
2025 Q4	$1.2M	Buy	607,330 +154,872	+34%	+$351K	﹤0.01%	759
2025 Q3	$1.11M	Buy	452,458 +199,990	+79%	+$515K	﹤0.01%	776
2025 Q2	$667K	Sell	252,468 -72,081	-22%	-$194K	﹤0.01%	829
2025 Q1	$977K	Sell	324,549 -225,356	-41%	-$683K	﹤0.01%	746
2024 Q4	$1.41M	Buy	549,905 +94,200	+21%	+$392K	0.01%	729
2024 Q3	$1.7M	Buy	455,705 +20,052	+5%	+$92.8K	0.01%	675
2024 Q2	$2.75M	Sell	435,653 -874,737	-67%	-$5.77M	0.01%	554
2024 Q1	$7.04M	Buy	1,310,390 +570,582	+77%	+$2.58M	0.03%	378
2023 Q4	$3.71M	Buy	+739,808	New	+$2.32M	0.02%	507
2023 Q1	–	Sell	-471,523	Closed	-$2.39M	–	1155
2022 Q4	$2.39M	Buy	471,523 +67,083	+17%	+$368K	0.02%	527
2022 Q3	$2.01M	Buy	404,440 +120,118	+42%	+$547K	0.02%	507
2022 Q2	$1.06M	Sell	284,322 -495,878	-64%	-$1.99M	0.01%	625
2022 Q1	$4.38M	Sell	780,200 -45,188	-5%	-$277K	0.03%	417
2021 Q4	$5.02M	Buy	825,388 +374,349	+83%	+$2.81M	0.03%	388
2021 Q3	$4.39M	Buy	451,039 +33,261	+8%	+$366K	0.03%	330
2021 Q2	$5.97M	Sell	417,778 -107,506	-20%	-$1.78M	0.04%	276
2021 Q1	$12.5M	Buy	525,284 +465,195	+774%	+$12.1M	0.09%	141
2020 Q4	$801K	Buy	+60,089	New	+$578K	0.01%	571